Correlation Between Visa and Royalty Pharma
Can any of the company-specific risk be diversified away by investing in both Visa and Royalty Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Visa and Royalty Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Visa Class A and Royalty Pharma Plc, you can compare the effects of market volatilities on Visa and Royalty Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Visa with a short position of Royalty Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Visa and Royalty Pharma.
Diversification Opportunities for Visa and Royalty Pharma
-0.79 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Visa and Royalty is -0.79. Overlapping area represents the amount of risk that can be diversified away by holding Visa Class A and Royalty Pharma Plc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Royalty Pharma Plc and Visa is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Visa Class A are associated (or correlated) with Royalty Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Royalty Pharma Plc has no effect on the direction of Visa i.e., Visa and Royalty Pharma go up and down completely randomly.
Pair Corralation between Visa and Royalty Pharma
Taking into account the 90-day investment horizon Visa Class A is expected to generate 1.05 times more return on investment than Royalty Pharma. However, Visa is 1.05 times more volatile than Royalty Pharma Plc. It trades about 0.1 of its potential returns per unit of risk. Royalty Pharma Plc is currently generating about 0.01 per unit of risk. If you would invest 27,135 in Visa Class A on September 2, 2024 and sell it today you would earn a total of 4,373 from holding Visa Class A or generate 16.12% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Visa Class A vs. Royalty Pharma Plc
Performance |
| Timeline |
| Visa Class A |
| Royalty Pharma Plc |
Visa and Royalty Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Visa and Royalty Pharma
The main advantage of trading using opposite Visa and Royalty Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Visa position performs unexpectedly, Royalty Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Royalty Pharma will offset losses from the drop in Royalty Pharma's long position.| Visa vs. American Express | Visa vs. PayPal Holdings | Visa vs. Capital One Financial | Visa vs. Upstart Holdings |
| Royalty Pharma vs. Prime Medicine, Common | Royalty Pharma vs. Ginkgo Bioworks Holdings | Royalty Pharma vs. Ocean Biomedical | Royalty Pharma vs. Adaptive Biotechnologies Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Other Complementary Tools
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |